Italy To Relax Biosimilar Switching Rules In Cost-Savings Effort

 
• By Ian Schofield
Reducing costs
Italy is encouraging biosimilar use to help reduce spending on biologic drugs

More from Biosimilars

More from Biosimilars & Generics